Josh Wolfe explores the broader implications of COVID-19 and what a path forward might look like. As Founder & Managing Director of Lux Capital, Josh invests in people who are inventing the future, like pioneers in the fields of nuclear waste clean up, metamaterials, satellites, and flying robots.
Josh Wolfe is a Co-Founder & Managing Director of VC fund Lux Capital, in NYC and Palo Alto investing in people, inventing the future. Josh focuses on contrarian investments in emerging technology. He’s a Co-Founder and Director at Kurion (doing high-tech nuclear waste in both Fukushima and US nuclear weapons cleanup complexes); at Kymeta (as Founding Investor and Director with Bill Gates and Nathan Myhrvold commercializing “metamaterials” for global satellite communications); at Shapeways (the world leader in 3d printing). Others include Planet Labs (which in 2014 launched the largest constellation of earth-imaging satellites) CyPhy(MIT-spawned flying commercial and military robots) Siluria (MIT-spinout converting natural gas to global chemicals) and Matterport (rapid 3D scanning). Current pursuits are computational imaging and sound, digital pathology, high-tech tattoo removal, and flavors & fragrances. Josh previously worked at SalomonSmithBarney and Merrill Lynch and published AIDS-immunopathology research in Cell Vision & The Journal of Leukocyte Biology. He’s a term member at the Council on Foreign Relations and a columnist and editor with Forbes. Josh is Co-Founder & Chairman of Coney Island Prep, a charter school in his native Coney Island, Brooklyn where he believes inner-city scholars need the right heroes and a deep desire to learn.